head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2022, vol. 28, issue1
Subject Area: Medicine
DOI: 10.5272/jimab.2022281.4264
Published online: 04 March 2022

Original article
J of IMAB. 2022 Jan-Mar;28(1):4264-4269
Mariya Ivanova1ORCID logo Corresponding Autoremail, Anna Todorova1ORCID logo, Lora Georgieva2ORCID logo, Magdalena Pesheva1ORCID logo,
1) Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University - Varna, Bulgaria.
2) Department of Social Medicine and Healthcare Organization, Faculty of Public Health, Medical University - Varna, Bulgaria.

Arterial hypertension (AH) is one of the main risk factors for cardiovascular diseases and mortality among the population. Major problems in treating hypertension are the lack of adherence and poor blood pressure control.
Purpose: To study the level of adherence to pharmacotherapy among hypertensive patients after the provision of specialised pharmaceutical care.
Materials/Methods: Pharmaceutical care has been provided through a custom-made algorithm for consulting hypertensive patients, designed by the authors. Community pharmacists, involved in the study, have been trained in advance to provide specialised pharmaceutical care to hypertensive patients. A direct anonymous questionnaire has been delivered to hypertensive patients. The questionnaire consists of two parts. The first part includes questions about demographic details, lifestyles, the frequency of blood pressure measurement, etc., and the second part is a validated tool - the Morisky Medication Adherence Scale.
Results: The study involved 50 patients with AH: 53% women and 47% men. After pharmaceutical care was provided through the established algorithm, 84% of the surveyed patients reported having no difficulties in the use of the prescribed medicines, and only 16% reported difficulties. Good management of blood pressure was observed in 73% of the respondents, while poor control was reported in only 27%. The Morisky coefficient for the study group was3.74, at a maximum score of 4, where the score for men was3.75 and for women – 3.72.
Conclusions: The studied sample group shows a very high level of adherence to the treatment and hence good blood pressure control. It can be assumed that the achieved outcomes are due to the specialised pharmaceutical care performed in accordance with the established algorithm.

Keywords: pharmaceutical care, hypertension, adherence,

pdf - Download FULL TEXT /PDF 1271 KB/
Please cite this article as: Ivanova M, Todorova A, Georgieva L, Pesheva M. Adherence to treatment among hypertensive patients as a result of specialised pharmaceutical care. J of IMAB. 2022 Jan-Mar;28(1):4264-4269. DOI: 10.5272/jimab.2022281.4264

Corresponding AutorCorrespondence to: Mariya Ivanova, Department of Pharmaceutical Sciences and Pharmaceutical Management, Faculty of Pharmacy, Medical University of Varna; 84, Tzar Osvoboditel str., Varna 9000, Bulgaria; E-mail: M.M.Ivanova@mu-varna.bg

1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021-3104. [PubMed]
2. Tobe SW, Moy Lum-Kwong M, Perkins N, Von Sychowski S, Sebaldt RJ, Kiss A. Heart and Stroke Foundation of Ontario (HSFO) high blood pressure strategy's hypertension management initiative study protocol. BMC Health Serv Res. 2008 Dec 10;8:251. [PubMed]
3. European health interview survey. National Statistical Institute, Bulgaria. 08.07.2021. [Internet]
4. Saseen JJ, MacLaughlin EJ. Chapter 13: Hypertension. In: Pharmacotherapy: A Pathophysiologic Approach. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. 10 edition. McGraw Hill. 2017. [Internet]
5. Treatment hypertension. Bulgarian Institute of Cardiology. 03.02.2021. [Internet]
6. - Adherence to Long-Term Therapies: Evidence for Action / [edited by Sabaté E.]  WHO. 2003. 196 p. [Internet]
7. Patel RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother. 2002 Jan;36(1):40-5. [PubMed]
8. Chen SL, Lee WL, Liang T, Liao IC. Factors associated with gender differences in medication adherence: a longitudinal study. J Adv Nurs. 2014 Sep;70(9):2031-2040. [PubMed]
9. Choi HY, Oh IJ, Lee JA, Lim J, Kim YS, Jeon TH, et al. Factors Affecting Adherence to Antihypertensive Medication. Korean J Fam Med. 2018 Nov; 39(6):325-332. [PubMed]
10. Krousel-Wood M, Hyre A, Muntner P, Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005 Jul;20(4):296-300. [PubMed]
11. Arabadzieva D, Petkova V, Csollei M, Dimitrov M, Andreevska K. Pharmaceutical care approach and hypertension. Eur J Pharm Med Res.2015 May;2(3):784-795. [Internet]
12. Lip GY, Beevers DG. Doctors, nurses, pharmacists and patients--the Rational Evaluation and Choice in Hypertension (REACH) survey of hypertension care delivery. Blood Press Suppl. 1997; 1:6-10. [PubMed]
13. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care - a pilot study. Pharm World Sci. 2005 Jun;27(3):202-7. [PubMed]
14. Stoimenova A, Draganov G, Manova M, Savova A, Petrova G. [Role of the pharmacist in the management of chronic diseases: hypertension.] [in Bulgarian] Cardiovascular diseases. 2011; 42(4):3-9.[Internet]
15. Todorova A. [Pharmaceutical care. Modern pharmaceutical approaches in uncontrolled patients with allergic rhinitis.] [Monograph] Varna. 2016. 110 p. [in Bulgarian]
16. Petkova VB, Petrova GI, Manova MM, Savoava AC, Kamusheva MS, Spasova-Mitkova ZE, et al. [Pharmaceutical care, textbook for pharmacy students.] Simel press, Sofia. 2018. [in Bulgarian]
17. MacLaughlin EJ, Saseen JJ.  Chapter 30: Hypertension. In: Pharmacotherapy: A Pathophysiologic Approach. DiPiro JT, Yee GC, L. Posey M, Haines ST, Nolin TD, Ellingrod V. 11 edition. McGraw Hill. 2020. [Internet]
18.  Whalen K. 27: Hypertension Medication Therapy Management Data Set. In: Medication Therapy Management: A Comprehensive Approach. Angaran DM, Whalen K. eds. McGraw Hill. 2015. [Internet]
19. CMAG-1. Case management adherence guideline; version 1.0.Chapter 7: Modified Morisky Scale. CMSA. June 1, 2004., pp.29-31. [Internet]
20. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002 Feb 25;162(4):413-20. [PubMed]
21. Tsvetkova А,  Mihaylova  S, Aleksandrova D. Analysis of factors affecting adherence to therapy in patients with chronic diseases. Scripta Scientifica Pharmaceutica. 2020;7(2):18-24.
22. Mitkova Z, Tashkov K, Dimitrova M, Manova M. [Influence of the therapeutic regime on the compliance with the therapy in patients with chronic diseases in Bulgaria.] Social Medicine. 2017; 2(3):29-32. [in Bulgarian]
23. Holmqvist L, Boström KB, Kahan T, Schiöler L, Qvarnström M, Wettermark B, et al. Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD). Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):315-321. [PubMed]
24. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag. 2008 Feb;4(1):269-86. [PubMed].

Received: 29 October 2021
Published online: 04 March 2022

back to Online Journal